RT Journal Article
T1 Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series.
A1 McCombe, Geoff
A1 Almaazmi, Bashayer
A1 Cullen, Walter
A1 Lambert, John S
A1 Avramovic, Gordana
A1 Murphy, Carol
A1 O'Connor, Mairead
A1 Perry, Nicola
A1 Ianache, Irina
A1 Lazar, Stefan
A1 McHugh, Tina
A1 Surey, Julian
A1 Macías, Juan
A1 Vickerman, Peter
A1 Oprea, Cristiana
AB It is increasingly being recognized that the elimination of HCV requires a multidisciplinary approach and effective cooperation between primary and secondary care. As part of a project (HepCare Europe) to integrate primary and secondary care for patients at risk of or infected with HCV, we developed a multidisciplinary educational Masterclass series for healthcare professionals (HCPs) working in primary care in Dublin and Bucharest. This article aims to describe and evaluate the series and examine how this model might be implemented into practice. GPs and other HCPs working in primary care, addiction treatment services and NGOs were invited to eight 1 day symposia (HCV Masterclass series), examining the burden and management of HCV in key populations. Peer-support sessions were also conducted, to give people affected by HCV and community-based organizations working with those directly affected, an update on the latest developments in HCV treatment. One hundred percent of participants 'strongly agreed' or 'agreed' that the Masterclass helped them to appreciate the role of integrated services in 'the management of patients with HCV'. One hundred percent of participants indicated the importance of a 'designated nurse to liaise with hospital services'. An improvement of knowledge regarding HCV management of patients with high-risk behaviour was registered at the end of the course. Integrated approaches to healthcare and improving the knowledge of HCPs and patients of the latest developments in HCV treatment are very important strategies that can enhance the HCV care pathway and treatment outcomes.
YR 2019
FD 2019
LK http://hdl.handle.net/10668/14770
UL http://hdl.handle.net/10668/14770
LA en
DS RISalud
RD Apr 7, 2025